Is Aspartame Really Safer in Reducing the Risk of Hypoglycemia During Exercise in Patients With Type 2 Diabetes?

Is Aspartame Really Safer in Reducing the Risk of Hypoglycemia During Exercise in Patients With Type 2 Diabetes?
2007
Annie Ferland, RD, MSC, Patrice Brassard, MSC and Paul Poirier, MD, PHD, FRCPC, FACC, FAHA
Diabetes Care

© 2007 by the American Diabetes Association

From the Institut Universitaire de Cardiologie et de Pneumologie, HŸpital Laval, Universit» Laval, Sainte-Foy, Qu»bec, Canada

Address correspondence to Paul Poirier, MD, PhD, FRCPC, FACC, FAHA, Institut Universitaire de Cardiologie et de Pneumologie, HŸpital Laval, 2725 Chemin Sainte-Foy, Sainte-Foy, Qu»bec, Canada G1V 4G5. E-mail: paul.poirier@crhl.ulaval.ca

In addition to physical activity and healthy food choices, low-calorie sweetening agents, such as aspartame, are a recommended alternative to sugar for patients with type 2 diabetes in order to obtain a better control of carbohydrate intake and blood glucose levels (1Ò3). The safety of aspartame has been a controversial issue for quite some time now. This noncarbohydrate sweetener is currently found in over 6,000 food products and beverages throughout the world. At present, its attractiveness as an artificial sweetener in the dietary management of diabetes is related to its 200-fold sweetening power and the lack of effect on plasma glucose levels compared with sucrose.

We have recently investigated the effect of different macronutrient compositions on plasma glucose and insulin levels during an acute bout of exercise in 14 men with type 2 diabetes. We compared the same subjects in random order in five different conditions: 1) highÒglycemic index sucrose meal, 2) lowÒglycemic index fructose meal (both of which are matched for total calories [455 kcal], macronutrient composition, and taste), 3) aspartame meal (358 kcal), 4) high-fat/low-carbohydrate meal (also containing 455 kcal), and 5) fasting. We hypothesized that using fructose or aspartame instead of sucrose would have a lower impact on insulin release and glucose response than a sucrose-sweetened meal.

Contrary to all expectation, the aspartame breakfast induced a similar rise in glucose and insulin levels at baseline than the sucrose meal, even if the aspartame meal had the same taste, and was 22% lower in calories and 10% lower in carbohydrates, with an inferior glycemic index. Indeed, the most dramatic reduction in plasma glucose level occurred in those with the highest 2-h postprandial plasma glucose levels (>8 mmol/l), i.e., after the sucrose, high-fat/low-carbohydrate and aspartame meals (magnitude of decrease of 44, 37, and 34%, respectively; all P < 0.001). However, the fructose meal induced the lowest fall in blood glucose, with a 31% decrease from baseline. An important fall was also observed in plasma insulin levels (78, 75, 73, and 68% for the sucrose, high-fat/low-carbohydrate, aspartame, and fructose meals, respectively; all P < 0.001), in contrast to the fasting state where there were no changes.

Moreover, considering that all sweetened meals (sucrose, fructose, and aspartame) in our study had the same taste, we can speculate that aspartame might have enhanced the cephalic phase of insulin secretion evoked by the recognition of the sweet taste, sight, smell, and expectation of food (4,5) and could have potentiated the drop in glucose levels during exercise. Although it has been reported that various forms of carbohydrate intake before exercise is safer for patients with diabetes in the prevention of exercise-induced hypoglycemia, we have reported severe symptoms of hypoglycemia on four occasions following sucrose- and/or aspartame-sweetened meals (6).

Considering the lack of evidence on the aspartame utilization in patients with type 2 diabetes (7Ò9), we consider that these clinical observations, in a exercise setting, raise important concerns regarding the safety of aspartame as suggested by international guidelines.

Acknowledgments

This work was supported by the Canadian Diabetes Association and the Foundation of the Corporation of the Quebec Heart Institute. A.F. is supported by the Canadian Institutes of Health Research (CIHR). P.B. is the recipient of a graduate research scholarship in pharmacy (PhD) from the Rx & D Health Research Foundation Awards Program funded in partnership with the CIHR. P.P. is a Clinician Scientist of the Fonds de la Recherche en Sant» du Qu»bec.

References

American Diabetes Association: Standards of medical care in diabetesÒ2006. Diabetes Care 29(Suppl. 1):S4ÒS42, 2006

Gougeon R, Spidel M, Lee K, Field CJ: Canadian Diabetes Association National Nutrition Committee Technical Review: non-nutritive intense sweeteners in diabetes management. Can J Diabetes 28:385Ò399, 2004

Canadian Diabetes Association: Clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 27(Suppl. 2):1Ò163, 2003

Bruce DG, Storlien LH, Furler SM, Chisholm DJ: Cephalic phase metabolic responses in normal weight adults. Metabolism 36:721Ò725, 1987[Medline]

Melanson KJ, Westerterp-Plantenga MS, Campfield LA, Saris WH: Blood glucose and meal patterns in time-blinded males, after aspartame, carbohydrate, and fat consumption, in relation to sweetness perception. Br J Nutr 82:437Ò446, 1999[Medline]

Ferland A, Turbide G, Bogaty P, Jobin J, LariviÀre MM, Poirier P: Type 2 diabetes and aerobic exercise: is breakfast deleterious (Abstract)? Med Sci Sports Exerc 36:S330, 2004

Colagiuri S, Miller JJ, Edwards RA: Metabolic effects of adding sucrose and aspartame to the diet of subjects with noninsulin-dependent diabetes mellitus. Am J Clin Nutr 50:474Ò478, 1989[Abstract/Free Full Text]

Horwitz DL, McLane M, Kobe P: Response to single dose of aspartame or saccharin by NIDDM patients. Diabetes Care 11:230Ò234, 1988[Abstract]

Shigeta H, Yoshida T, Nakai M, Mori H, Kano Y, Nishioka H, Kajiyama S, Kitagawa Y, Kanatsuna T, Kondo M, et al.: Effects of aspartame on diabetic rats and diabetic patients. J Nutr Sci Vitaminol (Tokyo) 31:533Ò540, 1985[Medline]